{"id":"W4283644627","doi":"10.1016/s1470-2045(22)00160-7","title":"2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19","year":2022,"lang":"en","type":"review","venue":"The Lancet Oncology","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":448,"is_retracted":false,"has_abstract":false,"ca_institutions":"McMaster University; McGill University Health Centre","funders":"National Institutes of Health; LEO Pharma; Servier; Astellas Pharma; Nippon Shinyaku; Société Académique de Genève; Incyte; International Society on Thrombosis and Haemostasis; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; CSL Behring; Alnylam Pharmaceuticals; Daiichi-Sankyo; Teva Pharmaceutical Industries; Daiichi Sankyo Europe; Sanofi; Amgen; National Heart, Lung, and Blood Institute; Pfizer; Celgene","keywords":"Medicine; Thrombosis; Rivaroxaban; Cancer; Venous thrombosis; Intensive care medicine; Apixaban; Internal medicine; Surgery; Warfarin; Atrial fibrillation","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002878803,0.001325964,0.002585552,0.00584357,0.0004522292,0.001544186,0.002169804,0.002878541,0.01248226],"category_scores_gemma":[0.007294531,0.0005416914,0.002656141,0.005415104,0.0005072926,0.0009852232,0.00107614,0.002620183,0.005711258],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002061659,"about_ca_system_score_gemma":0.01005139,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01164681,"about_ca_topic_score_gemma":0.01678669,"domain_scores_codex":[0.9982098,0.0004358915,0.0005482511,0.0001143523,0.0005840059,0.000107701],"domain_scores_gemma":[0.9959182,0.001603049,0.001007585,0.00007378933,0.001221564,0.0001758246],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"systematic_review","study_design_scores_codex":[0.0001646852,0.00009253008,0.0002409848,0.06865116,0.0003763769,0.0001179927,0.00007087555,0.0003240805,0.0005491703,0.002728791,0.2545691,0.6721143],"study_design_scores_gemma":[0.0002622056,0.00008785904,0.001604736,0.09097215,0.001030226,0.0003673133,0.0000547124,0.0001235839,0.0001535214,0.001801072,0.9035085,0.00003420309],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001128682,0.9832218,0.000617333,0.005405708,0.002189673,0.0003096774,0.001606061,0.00006202023,0.006474924],"genre_scores_gemma":[0.000700741,0.9880823,0.002441855,0.003771459,0.0006373848,0.0003285667,0.001720257,0.00001638591,0.002301142],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01248226,"threshold_uncertainty_score":0.04175729,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2762548973384936,"score_gpt":0.5170136550109575,"score_spread":0.240758757672464,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}